24 RCCA Physicians Named to 2025 Castle Connolly ‘Top Doctors’ List for Exceptional Cancer Care
A cancer diagnosis can be frightening. An individual may worry about how, or if, they will get better. The future becomes unclear and the strain
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
In general, doctors use four grades to classify brain tumors. This grading system is based on the nature, size and severity of the tumor and is essential for determining the appropriate treatment plan. Learn more about the different brain tumor grades from the expert oncologists of Regional Cancer Care Associates, who provide care to patients at 25 convenient locations in New Jersey, Connecticut, Maryland, and the Washington, D.C., area.
Grade I tumors are the least severe type and are usually benign, meaning they don’t contain cancerous cells. This type of tumor is not as likely as other grades of tumors to spread to other areas and usually can be removed surgically.
These tumors are similar to Grade I tumors in that they are not likely to spread to other parts of the brain. However, they may return even after treatment. The cells in a Grade II tumor look only slightly abnormal when a pathologist views a biopsy sample.
Grade III tumors grow and spread rapidly.
This is the most serious type of tumor. Grade IV means cells are dividing rapidly. Grade IV tumors usually spread quickly to other areas of the brain or spinal cord. The tumor also produces new blood vessels to stay alive. Often, there is a bundle of dead cells in the center of the tumor.
Surgeons determine the grade of a brain tumor by examining a sample of brain tissue obtained during surgery or through a needle biopsy, which often is performed with imaging guidance.
Physicians also use computed tomography (CT) scans or magnetic resonance imaging (MRI) to determine the location and size of the tumor, which provides further information to determine the best treatment plan.
Many factors can increase a person’s risk for brain cancer. For example, if a patient has existing cancer, it may spread to the brain. While cancers that begin in the brain cannot spread beyond the central nervous system, cancers anywhere else in the body can move – or metastasize — to the brain. In addition, exposure to radiation – from the workplace, cancer treatment or other sources — may increase the likelihood of cancer developing in the brain. Having a family history of cancer also is a risk factor for brain cancer.
Symptoms of brain cancer vary depending on how large the tumor is and where it is located in the brain. For example, tumors in the back of the brain may affect vision, balance, or movement. Signs of a potential brain tumor include:
These symptoms may represent a variety of conditions other than a brain tumor. Regardless, all warrant prompt medical evaluation and any of these symptoms that occur suddenly require immediate medical attention.
Early detection and treatment are vital for achieving the best possible outcomes with brain cancer. The sooner the tumor is found, the quicker patients can obtain treatment. There are many treatment options for those diagnosed with brain cancer, including:
If the tumor is easy to reach, total removal via surgery may be possible. However, surgeons may not be able to take out the entire tumor if it is located in a sensitive area of the brain.
In radiotherapy, high-energy radiation X-ray or proton beams are directed at the tumor from either outside the body or, in the case of brachytherapy, from tiny radioactive seeds implanted in or immediately next to the tumor. Radiosurgery involves a somewhat different approach, but also targets the brain tumor with radiation.
Medical therapies used to treat brain cancer include chemotherapy, in which drugs are administered to destroy cancer cells; immunotherapy, which harnesses the power of the body’s immune system to identify and attack cancer cells; and targeted therapy, in which medications kill or prevent the replication of cancer cells by acting on proteins or other molecules on the surface of the cells or inside the cells.
The team of oncology experts at Regional Cancer Care Associates is here to provide comprehensive, cutting-edge, and compassionate care for various cancers and blood disorders, including brain cancer, at our locations in New Jersey, Connecticut, Maryland, and the Washington, D.C., area. To learn more about brain cancer treatment, contact us today.
Doctors at Regional Cancer Care Associates (RCCA) are specialists in brain cancer. These experts have proven their leadership as professors, clinicians and researchers and were trained at the world’s most distinguished medical institutions. RCCA offers high-quality, advanced treatment near your home. We work with you and your family to make sure your care is second to none.
You can set up an appointment by calling the RCCA location nearest you. Or, for more information, call (844) 346-7222.
A cancer diagnosis can be frightening. An individual may worry about how, or if, they will get better. The future becomes unclear and the strain
Multiple myeloma (MM) is a rare type of blood cancer that often develops without early symptoms, making awareness of risk factors essential. Regional Cancer Care
A cancer diagnosis can bring a wide range of emotions, from fear and stress to sadness and hope. These feelings are a natural part of
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.